| Literature DB >> 34306088 |
Xiujuan Jia1,2, Chenxing Hu2, Xuepeng Zhu2, Ye Yuan2, Yifa Zhou2.
Abstract
A method using UPLC-HRMS has been developed for a rapid, simultaneous qualitative and quantitative analysis of twenty-five ginsenosides. Chromatographic separation was achieved on a C18 analytical column with an elution gradient comprising 0.1% aqueous formate/acetonitrile as the mobile phase. HRMS detection acquired full mass data for quantification and fullms-ddms2 (i.e., data-dependent scan mode) yielded product ion spectra for identification. Furthermore, quantitative analysis of multiginsenosides by single marker (QAMS) was developed and validated using a relative correction factor. Under optimal conditions, we could simultaneously separate eight groups of isomers of the 25 ginsenosides. Good linearity was observed over the validated concentration range for each analyte (r 2 > 0.9924), showing excellent sensitivity (LODs, 0.003-0.349 ng/mL) and lower limit quantification (LOQs, 0.015-1.163 ng/mL). The LC-MS external standard method (ESM) and QAMS were compared and successfully applied to analyze the ginsenoside content from Panax ginseng roots. Overall, our UPLC-HRMS/QAMS approach provides high precision, stability, and reproducibility and can be used for high-throughput analysis of complex ginsenosides and quantitative analysis of multiple components and quality control of traditional Chinese medicines (TCM).Entities:
Year: 2021 PMID: 34306088 PMCID: PMC8266465 DOI: 10.1155/2021/9986793
Source DB: PubMed Journal: Int J Anal Chem ISSN: 1687-8760 Impact factor: 1.885
Figure 1Total ion chromatograms. (a) Blank of methanol, (b) twenty-five ginsenoside standards, and (c) extract of Panax ginseng roots analyzed by UPLC-HRMS in negative ion mode.
Calibration curves, limit of quantification (LOQ), and limit of detection (LOD) of UPLC-MS methods for determination of 25 ginsenosides.
| Ginsenoside | RT | Calibration curve | Test range (ug/mL) |
| LOQ (ng/mL) | LOD (ng/mL) |
|---|---|---|---|---|---|---|
| Rg1 | 1.46 |
| 0.02-2 | 0.9990 | 0.106 | 0.032 |
| Re | 1.46 |
| 0.02-2 | 0.9959 | 0.164 | 0.049 |
| Rf | 4.08 |
| 0.01-0.5 | 0.9994 | 0.116 | 0.035 |
| Rh1 | 5.02 |
| 0.002-0.2 | 0.9994 | 0.025 | 0.007 |
| Rb1 | 5.44 |
| 0.02-2 | 0.9964 | 1.163 | 0.349 |
| Rg2 | 5.08 |
| 0.05-1 | 0.9924 | 0.012 | 0.003 |
| Rc | 6.09 |
| 0.01-1 | 0.9991 | 0.182 | 0.055 |
| F1 | 6.73 |
| 0.002-0.2 | 0.9995 | 0.029 | 0.009 |
| Rb2 | 7.13 |
| 0.01-1 | 0.9994 | 0.313 | 0.094 |
| Rb3 | 7.59 |
| 0.05-2 | 0.9994 | 0.513 | 0.154 |
| Rd | 9.25 |
| 0.1-2 | 0.9989 | 0.015 | 0.005 |
| G17 | 10.07 |
| 0.002-0.2 | 0.9998 | 0.217 | 0.065 |
| nFe | 10.8 |
| 0.002-0.2 | 0.9996 | 0.192 | 0.058 |
| CO | 11.61 |
| 0.001-0.2 | 0.9990 | 0.217 | 0.065 |
| nFd | 12.01 |
| 0.01-0.2 | 0.9959 | 0.833 | 0.250 |
| F2 | 13.68 |
| 0.002-0.2 | 0.9998 | 0.029 | 0.009 |
| G75 | 15.63 |
| 0.001-0.2 | 0.9991 | 0.042 | 0.013 |
| Rg3 | 15.89 |
| 0.002-0.2 | 0.9993 | 0.154 | 0.046 |
| PPT | 14.75 |
| 0.002-0.05 | 0.9984 | 0.150 | 0.045 |
| Mc | 17.29 |
| 0.001-0.2 | 0.9995 | 0.294 | 0.088 |
| CY | 18.02 |
| 0.001-0.2 | 0.9993 | 0.175 | 0.053 |
| CMx | 18.46 |
| 0.002-0.2 | 0.9990 | 0.189 | 0.057 |
| CK | 19.31 |
| 0.001-0.2 | 0.9998 | 0.018 | 0.005 |
| Rh2 | 19.6 |
| 0.002-0.2 | 0.9996 | 0.016 | 0.005 |
| PPD | 20.99 |
| 0.002-0.2 | 0.9990 | 0.535 | 0.160 |
Instrument precision, accuracy, sample stability, and repeatability of the assay (n = 6).
| Ginsenoside | Precision (RSD%) | Accuracy (RE%) | Stability (RSD%) | Repeatability (RSD%) |
|---|---|---|---|---|
| Rg1 | 0.88 | 0.06 | 1.05 | 0.92 |
| Re | 0.97 | 0.87 | 1.23 | 1.26 |
| Rf | 0.78 | 0.11 | 0.84 | 1.10 |
| Rh1 | 0.63 | 0.25 | 0.68 | 1.41 |
| Rb1 | 0.93 | 1.06 | 1.89 | 1.24 |
| Rg2 | 0.52 | 3.92 | 1.71 | 1.45 |
| Rc | 1.76 | 2.13 | 1.56 | 1.58 |
| F1 | 0.91 | 0.93 | 0.95 | 1.03 |
| Rb2 | 1.38 | 2.24 | 1.77 | 1.14 |
| Rb3 | 1.55 | 1.07 | 2.71 | 2.00 |
| Rd | 1.60 | 1.64 | 0.70 | 0.78 |
| GXVII | 0.79 | 0.31 | 2.14 | 2.01 |
| nFe | 1.93 | 0.22 | 3.77 | 3.31 |
| CO | 0.97 | 0.11 | 1.54 | 2.48 |
| nFd | 1.55 | 0.22 | 2.15 | 1.74 |
| F2 | 0.74 | 1.71 | 0.65 | 1.34 |
| G75 | 1.16 | 2.60 | 1.06 | 3.40 |
| Rg3 | 1.85 | 3.65 | 0.71 | 1.58 |
| PPT | 1.63 | 0.36 | 1.32 | 3.86 |
| Mc | 1.10 | 0.73 | 1.84 | 2.15 |
| CY | 1.02 | 0.19 | 2.87 | 1.86 |
| CMx | 0.67 | 0.17 | 1.36 | 1.39 |
| CK | 0.85 | 2.07 | 1.76 | 1.79 |
| Rh2 | 1.42 | 2.25 | 1.13 | 1.17 |
| PPD | 2.37 | 0.94 | 1.08 | 1.23 |
RSD, relative standard deviation, RE, relative error.
Characterization of compounds in Panax ginseng roots using UPLC-HRMS.
| No. | Identification | Formula |
| [M + COOH]− (m/z) | [M-H]−(m/z) | MS2 fragment ions (m/z) |
|---|---|---|---|---|---|---|
| 1 | 20-Glc-ginsenoside Rf | C48H82O19 | 1.05 | 1007.5447 | 961.5384 | 799.4883[M-H-Glc]–637.4325[M-H-2Glc]–475.3785[M-H-3G lc]– |
| 2 | Notoginsenoside R1 (nR1) | C47H80O18 | 1.17 | 977.5344 | 931.5288 | 799.4872[M- H-Xyl]–637.4320[M-H-Xyl-Glc]–475.3792[M-H-Xyl-2Glc]– |
| 3 | Ginsenoside Rg1 | C42H72O14 | 1.42 | 845.4910 | 799.4869 | 637.4324[M-H-Glc]–475.3803[M-H-2Glc]– |
| 4 | Ginsenoside Re | C48H82O18 | 1.46 | 991.5502 | 945.5451 | 799.4931[M-H-Rha]–783.4944[M-H-Glc]–637.4338[M-H-Glc-Rha]–475.3784[M-H-2Glc-Rha]– |
| 5 | Ginsenoside Rf | C42H72O14 | 4.05 | 845.4898 | 799.4855 | 637.4332[M-H-Glc]–475.3791[M-H-2Glc]– |
| 6 | Ginsenoside Ra3 | C59H100O27 | 4.33 | 1285.6436 | 1239.6372 | 1107.6023[M-H-Xyl]–945.5419[M-H-Xyl-Glc]–783.4863[M-H-Xyl-2Glc]–621.4360[M-H-Xyl-3Glc]– |
| 7 | Ginsenoside F3/F5 | C41H70O13 | 4.48 | 815.4810 | 769.4754 | 637.4333[M-H-Ara]–475.3789[M-H-Ara-Glc]– |
| 8 | Ginsenoside Rh1 | C36H62O9 | 4.96 | 683.4381 | 637.4322 | 475.3778[M-H-Glc]– |
| 9 | Ginsenoside Rg2 | C42H72O13 | 5.03 | 829.4963 | 783.4898 | 637.4306[M-H-Rha]–475.3807[M-H-Rha-Glc]– |
| 10 | Ginsenoside Ra2 | C58H98O26 | 5.23 | 1255.6328 | 1209.6276 | 1077.5858[M-H-Xyl]–945.5414[M-H-Xyl-Ara ( |
| 11 | Ginsenoside Rb1 | C54H92O23 | 5.40 | 1153.6014 | 1107.5956 | 945.5421[M-H-Glc]–783.4899[M-H-2Glc]–621.4374[M-H-3Glc]–459.3840[M-H-4Glc]– |
| 12 | Ginsenoside Rc | C53H90O22 | 6.06 | 1123.5912 | 1077.5854 | 945.5413[M-H-Ara ( |
| 13 | Ginsenoside Ra2-isomer | C58H98O26 | 6.27 | 1255.6329 | 1209.6266 | 1077.5870[M-H-Xyl]–945.5418[M-H-Xyl-Ara ( |
| 14 | Ginsenoside Ro | C48H76O19 | 6.44 | - | 955.4915 | 793.4398[M-H-Glc]–631.3837[M-H-2Glc]–455.3540[M-H-2Glc-GlcA]– |
| 15 | Ginsenoside F1 | C36H62O9 | 6.64 | 683.4385 | 637.4288 | 475.3827[M-H-Glc]– |
| 16 | Ginsenoside Ra1 | C58H98O26 | 6.68 | 1255.6334 | 1209.6271 | 1077.5790[M-H-Xyl]–783.4831[M-H-Xyl-Ara ( |
| 17 | Ginsenoside Rb2 | C53H90O22 | 7.09 | 1123.5912 | 1077.5859 | 945.5415[M-H-Ara ( |
| 18 | Ginsenoside Rb3 | C53H90O22 | 7.48 | 1123.5916 | 1077.5838 | 945.5406[M-H-Xyl]–783.4916[M-H-Xyl-Glc]–621.4372[M-H-Xyl-2Glc]–459.3855[M-H-Xyl-3Glc]– |
| 19 | Ginsenoside Ra1-isomer | C58H98O26 | 8.03 | 1255.6338 | 1209.6284 | 1077.5868[M-H-Xyl]–945.5466[M-H-Xyl-Ara ( |
| 20 | Chikusetsusaponin Iva (CS-Iva) | C42H66O14 | 8.91 | - | 793.4395 | 631.3858[M-H-Glc]–455.3555[M-H-Glc-GlcA]– |
| 21 | Ginsenoside Rd | C48H82O18 | 9.21 | 991.5497 | 945.5438 | 783.4911[M-H-Glc]–621.4377[M-H-2Glc]–459.3850[M-H-3Glc]– |
| 22 | Gypenoside XVII | C48H82O18 | 10.01 | 991.5506 | 945.5432 | 783.4890[M-H-Glc]–621.4405[M-H-2Glc]– |
| 23 | Notoginsenoside Fe (nFe) | C47H80O17 | 10.74 | 961.5374 | 915.5348 | 783.4901[M-H-Ara ( |
| 24 | Compound O (CO) | C47H80O17 | 11.17 | 961.5401 | 915.5327 | 783.4915[M-H-Ara ( |
| 25 | NotoginsenosideFd (nFd) | C47H80O17 | 11.54 | 961.5401 | 915.5330 | 783.4908[M-H-Xyl]–621.4370[M-H-Xyl-Glc]–459.3854[M-H-Xyl-2Glc]– |
| 26 | Ginsenoside Rg6 | C42H70O12 | 12.09 | 811.4872 | 765.4798 | 619.4215[M-H -Rha]– |
| 27 | Ginsenoside Rk3 | C36H60O8 | 12.51 | 665.4287 | 619.3349 | — |
| 28 | Ginsenoside F4 | C42H70O12 | 12.90 | 811.4871 | 765.4786 | 619.4219[M-H-Rha]–457.3643[M-H-Rha-Glc]– |
| 29 | Ginsenoside Rh4 | C36H60O8 | 13.24 | 665.4284 | 619.3344 | — |
| 30 | Ginsenoside F2 | C42H72O13 | 13.62 | 829.4974 | 783.4861 | 621.4400[M-H-Glc]–459.3816[M-H-2Glc]– |
| 31 | PPT | C30H52O4 | 14.69 | 521.3853 | 475.3792 | — |
| 32 | Glycoside D3a | C42H66O14 | 14.70 | - | 793.4392 | 613.3735[M-H-Glc-H2O]–455.3517[M-H-Glc-GlcA]– |
| 33 | Gypenoside LXXV (G75) | C42H72O13 | 15.51 | 829.4975 | 783.4913 | 621.4393[M-H-Glc]–459.3844[M-H-2Glc]– |
| 34 | Ginsenoside Rg3 | C42H72O13 | 15.79 | 829.4951 | 783.4912 | 621.4393[M-H-Glc]–459.3845[M-H-2Glc]– |
| 35 | 20 (R)-Rg3 | C42H72O13 | 16.28 | 829.4974 | 783.4905 | 621.4382[M-H-Glc]–459.3864[M-H-2Glc]– |
| 36 | Ginsenoside Mc | C41H70O12 | 17.31 | 799.4866 | 753.4793 | 621.4371[M-H-Ara ( |
| 37 | Compound Y (CY) | C41H70O12 | 17.94 | 799.4868 | 753.4804 | 621.4374[M-H-Ara ( |
| 38 | Compound Mx (CMx) | C41H70O12 | 18.42 | 799.4869 | 753.4770 | 621.4406[M-H-Xyl]–459.3858[M-H-Xyl-Glc]– |
| 39 | Compound K (CK) | C36H62O8 | 19.30 | 667.4473 | 621.4392 | 459.3828[M-H-Glc]– |
| 40 | Ginsenoside Rk1 | C42H70O12 | 19.46 | 811.4865 | 765.4803 | 603.4224[M-H-Glc]– |
| 41 | Ginsenoside Rg5 | C42H70O12 | 19.55 | 811.4869 | 765.4843 | 603.4230[M-H-Glc]– |
| 42 | Ginsenoside Rh2 | C53H90O22 | 19.59 | 667.4438 | 621.4372 | 459.3831[M-H-Glc]– |
| 43 | PPD | C30H52O3 | 20.99 | 505.3909 | 459.3843 | — |
Identified with a standard reference.
Figure 2The MS/MS spectrum of ginsenoside-Rb1 (a), ginsenoside-Re (b), and ginsenoside-CS-Iva (c).
Relative response factor (RCF) and relative standard deviation (RSD) values of 25 ginsenosides.
| Ginsenoside | Concentration (ng/mL) | Mean | RSD (%) | ||||
|---|---|---|---|---|---|---|---|
| 10 | 20 | 50 | 100 | 200 | |||
| Rb2 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | — | — |
| Rg1 | 0.32 | 0.30 | 0.31 | 0.30 | 0.30 | 0.31 | 2.92 |
| Re | 0.48 | 0.46 | 0.47 | 0.48 | 0.46 | 0.47 | 2.13 |
| Rf | 0.48 | 0.48 | 0.52 | 0.48 | 0.50 | 0.49 | 3.64 |
| Rb1 | 3.45 | 3.25 | 3.05 | 3.18 | 3.22 | 3.23 | 4.48 |
| Rg2 | 0.44 | 0.43 | 0.46 | 0.42 | 0.42 | 0.43 | 3.86 |
| Rh1 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.09 | 5.08 |
| Rc | 0.93 | 0.88 | 0.94 | 0.94 | 0.92 | 0.92 | 2.70 |
| F1 | 0.07 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 2.83 |
| Rb3 | 0.97 | 0.97 | 0.98 | 0.99 | 0.98 | 0.98 | 0.86 |
| Rd | 0.36 | 0.34 | 0.35 | 0.34 | 0.34 | 0.35 | 2.59 |
| GXVII | 0.24 | 0.24 | 0.25 | 0.23 | 0.24 | 0.24 | 2.95 |
| nFe | 0.62 | 0.67 | 0.66 | 0.69 | 0.68 | 0.66 | 4.07 |
| CO | 0.60 | 0.62 | 0.63 | 0.66 | 0.65 | 0.63 | 3.78 |
| nFd | 1.05 | 1.00 | 1.05 | 0.99 | 1.05 | 1.03 | 2.95 |
| F2 | 0.10 | 0.10 | 0.09 | 0.10 | 0.10 | 0.10 | 4.56 |
| G75 | 0.09 | 0.09 | 0.09 | 0.08 | 0.09 | 0.09 | 5.08 |
| Rg3 | 0.14 | 0.14 | 0.14 | 0.13 | 0.14 | 0.14 | 3.24 |
| PPT | 1.00 | 0.97 | 0.95 | 0.99 | 1.01 | 0.98 | 2.45 |
| Mc | 0.33 | 0.34 | 0.34 | 0.36 | 0.34 | 0.34 | 3.20 |
| CY | 0.47 | 0.48 | 0.50 | 0.49 | 0.47 | 0.48 | 2.71 |
| CMx | 0.24 | 0.25 | 0.25 | 0.26 | 0.25 | 0.25 | 2.83 |
| CK | 0.14 | 0.13 | 0.14 | 0.15 | 0.14 | 0.14 | 5.05 |
| Rh2 | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 3.24 |
| PPD | 6.48 | 6.95 | 6.67 | 6.98 | 6.45 | 6.71 | 3.75 |
Effects of column temperature and flow rate upon relative response factor (RCF) and relative retention time (RTR).
| Effects of column temperature | Effects of flow rate | |||||||
|---|---|---|---|---|---|---|---|---|
| RCF | RT | RCF | RT | |||||
| Ginsenoside | Mean | RSD% | Mean | RSD% | Mean | RSD% | Mean | RSD% |
| Rg1 | 0.29 | 3.45 | 0.21 | 0.00 | 0.30 | 3.33 | 0.22 | 5.33 |
| Re | 0.47 | 2.44 | 0.21 | 0.00 | 0.49 | 2.37 | 0.22 | 4.55 |
| Rf | 0.48 | 1.21 | 0.56 | 1.79 | 0.48 | 1.19 | 0.58 | 1.00 |
| Rb1 | 3.08 | 3.83 | 0.77 | 0.75 | 3.19 | 1.58 | 0.76 | 2.02 |
| Rg2 | 0.34 | 4.45 | 0.70 | 1.43 | 0.35 | 1.63 | 0.72 | 0.81 |
| Rh1 | 0.09 | 3.94 | 0.70 | 1.66 | 0.09 | 3.32 | 0.71 | 0.00 |
| Rc | 0.91 | 3.34 | 0.86 | 0.67 | 0.92 | 0.00 | 0.85 | 1.18 |
| F1 | 0.08 | 0.00 | 0.95 | 0.61 | 0.08 | 0.00 | 0.96 | 1.04 |
| Rb3 | 0.98 | 3.11 | 1.06 | 0.00 | 0.99 | 1.01 | 1.07 | 0.54 |
| Rd | 0.32 | 3.13 | 1.29 | 0.45 | 0.33 | 1.73 | 1.24 | 5.26 |
| GXVII | 0.25 | 4.00 | 1.41 | 0.41 | 0.25 | 2.28 | 1.36 | 4.80 |
| nFe | 0.67 | 1.49 | 1.52 | 0.38 | 0.68 | 0.85 | 1.46 | 4.12 |
| CO | 0.64 | 2.40 | 1.64 | 0.71 | 0.63 | 2.44 | 1.58 | 3.16 |
| nFd | 1.06 | 1.44 | 1.69 | 0.34 | 1.05 | 1.45 | 1.64 | 3.37 |
| F2 | 0.10 | 5.97 | 1.92 | 0.52 | 0.10 | 0.00 | 1.95 | 6.48 |
| G75 | 0.09 | 3.27 | 2.19 | 0.00 | 0.09 | 4.61 | 2.12 | 3.55 |
| Rg3 | 0.13 | 4.56 | 2.21 | 0.90 | 0.13 | 0.00 | 2.16 | 3.50 |
| PPT | 1.03 | 2.03 | 2.05 | 1.49 | 1.02 | 1.96 | 1.96 | 5.61 |
| Mc | 0.34 | 2.94 | 2.43 | 0.24 | 0.35 | 1.67 | 2.33 | 4.54 |
| CY | 0.45 | 4.44 | 2.53 | 0.40 | 0.45 | 3.37 | 2.41 | 6.08 |
| CMx | 0.26 | 3.85 | 2.59 | 1.68 | 0.28 | 5.52 | 2.45 | 7.54 |
| CK | 0.11 | 5.41 | 2.69 | 1.14 | 0.10 | 5.59 | 2.53 | 7.50 |
| Rh2 | 0.07 | 5.09 | 2.72 | 1.18 | 0.07 | 3.36 | 2.57 | 7.60 |
| PPD | 6.76 | 1.78 | 2.90 | 1.43 | 6.73 | 1.43 | 2.75 | 7.46 |
Comparative experiment results of the external standard method (ESM) and quantitative analysis of multiginsenosides by single marker method (QAMS) (mg/g).
| No. | Ginsenoside | ESM | QAMS | SMD% |
|---|---|---|---|---|
| 1 | Rg1 | 53.85 | 53.80 | 0.10 |
| 2 | Re | 151.28 | 143.83 | 4.92 |
| 3 | Rf | 29.34 | 29.47 | 0.46 |
| 4 | Rb1 | 324.15 | 316.05 | 2.50 |
| 5 | Rg2 | 29.22 | 30.21 | 3.38 |
| 6 | Rh1 | 1.39 | 1.35 | 2.54 |
| 7 | Rc | 97.77 | 96.82 | 0.97 |
| 8 | F1 | 0.55 | 0.57 | 2.52 |
| 9 | Rb2 | 112.03 | 112.03 | - |
| 10 | Rb3 | 17.94 | 17.88 | 0.38 |
| 11 | Rd | 97.66 | 98.03 | 0.38 |
| 12 | GXVII | 2.56 | 2.54 | 0.91 |
| 13 | nFe | 3.92 | 3.71 | 5.33 |
| 14 | CO | 2.22 | 2.20 | 0.52 |
| 15 | nFd | 1.75 | 1.76 | 0.50 |
| 16 | F2 | 1.25 | 1.24 | 0.71 |
| 17 | G75 | 0.11 | 0.10 | 5.45 |
| 18 | Rg3 | 2.95 | 2.86 | 3.05 |
| 19 | PPT | 1.03 | 1.01 | 1.53 |
| 20 | Mc | 0.91 | 0.88 | 3.69 |
| 21 | CY | 2.42 | 2.42 | 0.21 |
| 22 | CMx | 0.38 | 0.37 | 1.40 |
| 23 | CK | 1.42 | 1.41 | 0.18 |
| 24 | Rh2 | 0.33 | 0.32 | 4.12 |
| 25 | PPD | 0.47 | 0.46 | 2.09 |